Drugs Made In America Acquisition II Corp.
DMII · XNASCIK 2040475fmd_1DK88FMJRA2VKRWMEY77V75YARFinance, Insurance and Real Estate · Blank ChecksTemplate: Standard
Coverage: Jan 01, 2025 to Jun 30, 2026, 6 periods
Latest annual · FY2025
Millions- Operating income
- (0)
- Net income
- 4
Latest quarter · Q2 FY2026
Millions- Operating income
- (0)
- Net income
- 4
Drugs Made In America Acquisition II Corp. (DMII) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | Change | Source | |
|---|---|---|---|---|
| Operating income | -$488,385 | 10-K 2026-04-15 · proof | ||
| Net income | $4.2 million | 10-K 2026-04-15 · proof | ||
| Cash from operating activities | -$1 million | 10-K 2026-04-15 · proof | ||
| Total assets | $505 million | 10-K 2026-04-15 · proof | ||
| Total liabilities | $17.8 million | 10-K 2026-04-15 · proof | ||
| Cash and cash equivalents | $223 | 10-K 2026-04-15 · proof |
- What was Drugs Made In America Acquisition II Corp. (DMII)'s operating income in fiscal 2025?
- Drugs Made In America Acquisition II Corp. (DMII) reported operating income of -$488,385 for fiscal 2025 (the year ended Dec 31, 2025). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What was Drugs Made In America Acquisition II Corp. (DMII)'s net income in fiscal 2025?
- Drugs Made In America Acquisition II Corp. (DMII) reported net income of $4.2 million for fiscal 2025 (the year ended Dec 31, 2025). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What was Drugs Made In America Acquisition II Corp. (DMII)'s cash from operating activities in fiscal 2025?
- Drugs Made In America Acquisition II Corp. (DMII) reported cash from operating activities of -$1 million for fiscal 2025 (the year ended Dec 31, 2025). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are Drugs Made In America Acquisition II Corp. (DMII)'s total assets?
- As of Dec 31, 2025, Drugs Made In America Acquisition II Corp. (DMII) reported total assets of $505 million. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are Drugs Made In America Acquisition II Corp. (DMII)'s total liabilities?
- As of Dec 31, 2025, Drugs Made In America Acquisition II Corp. (DMII) reported total liabilities of $17.8 million. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are Drugs Made In America Acquisition II Corp. (DMII)'s cash and cash equivalents?
- As of Dec 31, 2025, Drugs Made In America Acquisition II Corp. (DMII) reported cash and cash equivalents of $223. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:DMII&period_type=annual&limit=5"Information only, not investment advice.